Analyst Price Targets — DDS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 25, 2026 2:26 pm | — | Telsey Advisory | $650.00 | $606.68 | TheFly | Dillard's price target lowered to $650 from $700 at Telsey Advisory |
| November 28, 2025 12:26 pm | Mauricio Serna | UBS | $460.00 | $669.49 | StreetInsider | Dillard's Inc. (DDS) PT Raised to $460 at UBS: 'Adept to Drive Modest Sales Growth' |
| August 16, 2024 9:44 am | Dana Telsey | Telsey Advisory | $380.00 | $349.65 | TheFly | Dillard's price target lowered to $380 from $475 at Telsey Advisory |
| August 15, 2024 10:26 am | Zachary Warring | CFRA | $372.00 | $354.22 | StreetInsider | CFRA Downgrades Dillard's Inc. (DDS) to Hold |
| May 16, 2024 1:59 pm | Mauricio Serna | UBS | $192.00 | $434.45 | StreetInsider | UBS Reiterates Sell Rating on Dillard's Inc. (DDS) |
| May 16, 2024 1:44 pm | Zachary Warring | CFRA | $500.00 | $434.45 | StreetInsider | CFRA Reiterates Buy Rating on Dillard's Inc. (DDS) |
Latest News for DDS
A Nostalgic, Limited-Edition Capsule Collection Inspired by Coastal Ease LITTLE ROCK, Ark., April 07, 2026 (GLOBE NEWSWIRE) -- Dillard's, Inc. (“Dillard's”) (NYSE: DDS) is pleased to introduce Cyd Morris x Gianni Bini.
Dillard's, Inc. (NYSE: DDS - Get Free Report) has earned a consensus recommendation of "Reduce" from the five brokerages that are covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation and three have issued a hold recommendation on the company. The average 12-month target price among analysts that have
LITTLE ROCK, Ark., March 02, 2026 (GLOBE NEWSWIRE) -- Dillard's, Inc. (“Dillard's”) (NYSE: DDS) is pleased to introduce Amanda Jones Vaughan x Antonio Melani.
DDS beats Q4 EPS estimates but misses on revenues as comps slip 1% and shares tumble 8% on weak sales and a cautious demand outlook.
Pre-market futures are busy climbing out of the deep hole Monday's market dug for itself, particularly on the blue-chip Dow index. Tariff concerns and possible military conflict with Iran are issues that have not gone away, but neither have they poisoned the well.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DDS.
U.S. House Trading
No House trades found for DDS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.